about
Effects of Small Molecule Calcium-Activated Chloride Channel Inhibitors on Structure and Function of Accessory Cholera Enterotoxin (Ace) of Vibrio choleraeChemotherapy-Induced Constipation and Diarrhea: Pathophysiology, Current and Emerging TreatmentsA functional CFTR assay using primary cystic fibrosis intestinal organoidsAntidiarrheal efficacy and cellular mechanisms of a Thai herbal remedyInhibition of cAMP-activated intestinal chloride secretion by diclofenac: cellular mechanism and potential application in choleraElectrophysiological Studies into the Safety of the Anti-diarrheal Drug Clotrimazole during Oral Rehydration TherapyIntestinal Enteroids Model Guanylate Cyclase C-Dependent Secretion Induced by Heat-Stable Enterotoxins.Chloride channel inhibition by a red wine extract and a synthetic small molecule prevents rotaviral secretory diarrhoea in neonatal miceCystic fibrosis transmembrane conductance regulator chloride channel blockers: Pharmacological, biophysical and physiological relevance.Inhibition of Heat-Stable Toxin-Induced Intestinal Salt and Water Secretion by a Novel Class of Guanylyl Cyclase C Inhibitors.CFTR inhibitors.An Adult Mouse Model of Vibrio cholerae-induced Diarrhea for Studying Pathogenesis and Potential Therapy of Cholera.Microfluidics platform for single-shot dose-response analysis of chloride channel-modulating compoundsBioactivity-guided fractionation of an antidiarrheal Chinese herb Rhodiola kirilowii (Regel) Maxim reveals (-)-epicatechin-3-gallate and (-)-epigallocatechin-3-gallate as inhibitors of cystic fibrosis transmembrane conductance regulator.Human rotavirus strain Wa downregulates NHE1 and NHE6 expressions in rotavirus-infected Caco-2 cells.Convective washout reduces the antidiarrheal efficacy of enterocyte surface-targeted antisecretory drugsCrofelemer for the treatment of chronic diarrhea in patients living with HIV/AIDSPathophysiological mechanisms of diarrhea caused by the Vibrio cholerae O1 El Tor variant: an in vivo study in mice.Microfluidics platform for measurement of volume changes in immobilized intestinal enteroids.Functional architecture of the CFTR chloride channel.Ginsenoside Rb1, a novel activator of the TMEM16A chloride channel, augments the contraction of guinea pig ileum.Connexin 26 facilitates gastrointestinal bacterial infection in vitro.Cystic Fibrosis Transmembrane Conductance Regulator (CFTR): CLOSED AND OPEN STATE CHANNEL MODELS.Genistein inhibits rotavirus replication and upregulates AQP4 expression in rotavirus-infected Caco-2 cells.Potentiators exert distinct effects on human, murine, and Xenopus CFTR.High CFTR expression in Philadelphia chromosome-positive acute leukemia protects and maintains continuous activation of BCR-ABL and related signaling pathways in combination with PP2A.Microbiota-related Changes in Bile Acid & Tryptophan Metabolism are Associated with Gastrointestinal Dysfunction in a Mouse Model of Autism.AMP-activated protein kinase and adenosine are both metabolic modulators regulating chloride secretion in the shark rectal gland (Squalus acanthias).
P2860
Q27312038-64CA8132-1EE4-4BA8-A44A-91D20CD2BD82Q28079705-6613118E-196A-4B5B-B3E7-6EE043AC611EQ28291898-2DEE5C62-2314-4A64-ADBE-C32BD3F99083Q28539765-2FB02461-923E-45A3-B351-90B3C8235796Q28542764-B3AFC991-B43C-4C2C-B393-5DA35C4A7DFBQ28548532-BC03C00B-7A6F-4D6E-AF81-817FDE365737Q30815469-C36BE954-DF16-4422-8236-4F29ADBC9B39Q33723721-001774C2-BC1E-4FB9-9F8E-ABEC23C4AC46Q34408604-1CE554EF-B2A2-4DB6-B514-6FFE7218A0C8Q34477345-C62B7C7B-8AC5-48F0-8D90-2C3E5D1B6097Q34553829-A246E1B6-9933-4992-961F-FF4BF9D55DDAQ34798092-4CBD1758-A83F-4C68-B6F5-FA1A56616190Q34888430-B2332219-9D75-422B-B75B-CBD81EA88BFCQ35154679-09A70206-FD97-4754-99F9-A4F22B1C92D9Q36307019-46D132C8-62BA-4DFB-B41B-1DB0A4CA9494Q36568476-82166846-515B-4615-9808-95A2C904869CQ37042269-1559E4E0-13DA-4432-AD85-7928907082FDQ37268441-0D32D6A3-8F43-49B8-BD86-871DE116384FQ37685939-FC54BD41-1F72-4773-A4D4-4F1F8BB0BCE8Q38171539-571F1E83-B940-4782-A6B2-8FC5CA47F877Q38998291-35BFFE25-2ADD-48EF-BDC0-3DB42957A5CDQ39247565-3FC7CAA4-3368-47F7-A5A8-66D7D9BFB9B1Q40675000-CAD05B72-290D-46C2-80B7-9E812F588769Q41331021-120C6A75-3E43-462E-AB5B-232DF29A841FQ41986673-7C8C9F23-92D7-48BC-AC70-4123EBCD00C7Q42285165-3445868B-6FCB-4DBF-9647-D72B7EAFBBDBQ42651339-AAA673CA-5D84-4348-9FFB-E7509187CEA0Q49918213-43AD1C27-B03F-4CCD-8ED1-E53779D73A05
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
CFTR inhibitors for treating diarrheal disease
@ast
CFTR inhibitors for treating diarrheal disease
@en
CFTR inhibitors for treating diarrheal disease
@nl
type
label
CFTR inhibitors for treating diarrheal disease
@ast
CFTR inhibitors for treating diarrheal disease
@en
CFTR inhibitors for treating diarrheal disease
@nl
prefLabel
CFTR inhibitors for treating diarrheal disease
@ast
CFTR inhibitors for treating diarrheal disease
@en
CFTR inhibitors for treating diarrheal disease
@nl
P2860
P356
P1476
CFTR inhibitors for treating diarrheal disease
@en
P2093
A S Verkman
J R Thiagarajah
P2860
P304
P356
10.1038/CLPT.2012.114
P407
P577
2012-09-01T00:00:00Z